Cargando…
Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1
The prevention of metastasis is a central goal of cancer therapy. Caveolin-1 (Cav-1) is a structural membrane and scaffolding protein shown to be a key regulator of late-stage breast cancer metastasis. However, therapeutic strategies targeting Cav-1 are still lacking. Here, we demonstrate that the p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368491/ https://www.ncbi.nlm.nih.gov/pubmed/35954304 http://dx.doi.org/10.3390/cells11152461 |
_version_ | 1784766149710315520 |
---|---|
author | Jiang, Ying Senyuk, Vitalyi Ma, Ke Chen, Hui Qin, Xiang Li, Shun Liu, Yiyao Gentile, Saverio Minshall, Richard D. |
author_facet | Jiang, Ying Senyuk, Vitalyi Ma, Ke Chen, Hui Qin, Xiang Li, Shun Liu, Yiyao Gentile, Saverio Minshall, Richard D. |
author_sort | Jiang, Ying |
collection | PubMed |
description | The prevention of metastasis is a central goal of cancer therapy. Caveolin-1 (Cav-1) is a structural membrane and scaffolding protein shown to be a key regulator of late-stage breast cancer metastasis. However, therapeutic strategies targeting Cav-1 are still lacking. Here, we demonstrate that the pharmacological activation of potassium channel Kv11.1, which is uniquely expressed in MDA-MB-231 triple negative breast cancer cells (TNBCs) but not in normal MCF-10A cells, induces the dephosphorylation of Cav-1 Tyr-14 by promoting the Ca(2+)-dependent stimulation of protein tyrosine phosphatase 1B (PTP1B). Consequently, the dephosphorylation of Cav-1 resulted in its disassociation from β-catenin, which enabled the accumulation of β-catenin at cell borders, where it facilitated the formation of cell–cell adhesion complexes via interactions with R-cadherin and desmosomal proteins. Kv11.1 activation-dependent Cav-1 dephosphorylation induced with NS1643 also reduced cell migration and invasion, consistent with its ability to regulate focal adhesion dynamics. Thus, this study sheds light on a novel pharmacological mechanism of promoting Cav-1 dephosphorylation, which may prove to be effective at reducing metastasis and promoting contact inhibition. |
format | Online Article Text |
id | pubmed-9368491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93684912022-08-12 Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1 Jiang, Ying Senyuk, Vitalyi Ma, Ke Chen, Hui Qin, Xiang Li, Shun Liu, Yiyao Gentile, Saverio Minshall, Richard D. Cells Article The prevention of metastasis is a central goal of cancer therapy. Caveolin-1 (Cav-1) is a structural membrane and scaffolding protein shown to be a key regulator of late-stage breast cancer metastasis. However, therapeutic strategies targeting Cav-1 are still lacking. Here, we demonstrate that the pharmacological activation of potassium channel Kv11.1, which is uniquely expressed in MDA-MB-231 triple negative breast cancer cells (TNBCs) but not in normal MCF-10A cells, induces the dephosphorylation of Cav-1 Tyr-14 by promoting the Ca(2+)-dependent stimulation of protein tyrosine phosphatase 1B (PTP1B). Consequently, the dephosphorylation of Cav-1 resulted in its disassociation from β-catenin, which enabled the accumulation of β-catenin at cell borders, where it facilitated the formation of cell–cell adhesion complexes via interactions with R-cadherin and desmosomal proteins. Kv11.1 activation-dependent Cav-1 dephosphorylation induced with NS1643 also reduced cell migration and invasion, consistent with its ability to regulate focal adhesion dynamics. Thus, this study sheds light on a novel pharmacological mechanism of promoting Cav-1 dephosphorylation, which may prove to be effective at reducing metastasis and promoting contact inhibition. MDPI 2022-08-08 /pmc/articles/PMC9368491/ /pubmed/35954304 http://dx.doi.org/10.3390/cells11152461 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jiang, Ying Senyuk, Vitalyi Ma, Ke Chen, Hui Qin, Xiang Li, Shun Liu, Yiyao Gentile, Saverio Minshall, Richard D. Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1 |
title | Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1 |
title_full | Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1 |
title_fullStr | Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1 |
title_full_unstemmed | Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1 |
title_short | Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1 |
title_sort | pharmacological activation of potassium channel kv11.1 with ns1643 attenuates triple negative breast cancer cell migration by promoting the dephosphorylation of caveolin-1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368491/ https://www.ncbi.nlm.nih.gov/pubmed/35954304 http://dx.doi.org/10.3390/cells11152461 |
work_keys_str_mv | AT jiangying pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT senyukvitalyi pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT make pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT chenhui pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT qinxiang pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT lishun pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT liuyiyao pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT gentilesaverio pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 AT minshallrichardd pharmacologicalactivationofpotassiumchannelkv111withns1643attenuatestriplenegativebreastcancercellmigrationbypromotingthedephosphorylationofcaveolin1 |